Bank of America Begins Coverage on Elanco Animal Health (ELAN)

Research analysts at Bank of America began coverage on shares of Elanco Animal Health (NASDAQ:ELAN) in a research note issued to investors on Monday, Marketbeat.com reports. The firm set a “neutral” rating and a $34.00 price target on the stock. Bank of America’s target price would indicate a potential upside of 4.26% from the company’s current price.

ELAN has been the topic of a number of other research reports. Gabelli started coverage on Elanco Animal Health in a research note on Wednesday, September 19th. They issued a “buy” rating and a $32.00 price target on the stock. BMO Capital Markets started coverage on Elanco Animal Health in a research note on Wednesday, September 26th. They issued a “market perform” rating and a $33.00 price target on the stock. Craig Hallum started coverage on Elanco Animal Health in a research note on Friday, October 12th. They issued a “hold” rating on the stock. Goldman Sachs Group started coverage on Elanco Animal Health in a research note on Monday. They issued a “neutral” rating and a $30.00 price target on the stock. Finally, JPMorgan Chase & Co. started coverage on Elanco Animal Health in a research note on Monday. They issued an “overweight” rating and a $38.00 price target on the stock. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $34.38.

Shares of Elanco Animal Health stock opened at $32.61 on Monday. Elanco Animal Health has a 12-month low of $31.50 and a 12-month high of $37.61.

In other news, CEO Jeffrey N. Simmons acquired 22,000 shares of the stock in a transaction on Monday, September 24th. The shares were purchased at an average price of $24.00 per share, for a total transaction of $528,000.00. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Lawrence Erik Kurzius acquired 10,000 shares of the stock in a transaction on Monday, September 24th. The shares were purchased at an average price of $24.00 per share, for a total transaction of $240,000.00. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 33,000 shares of company stock worth $792,000.

An institutional investor recently bought a new position in Elanco Animal Health stock. First Manhattan Co. acquired a new position in shares of Elanco Animal Health (NASDAQ:ELAN) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 10,000 shares of the company’s stock, valued at approximately $348,000.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Recommended Story: Moving Average (MA)

Analyst Recommendations for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply